TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20831826

Group type: EXPERIMENTAL
Intervention: Exploratory prediction configural frequency analysis (CFA) on one-half of the sample (n = 1969)
Number of subjects: 3883

Group type: EXPERIMENTAL
Intervention: Confirmatory prediction CFA on the second half (n = 1914)
Number of subjects: 3883

Group type: EXPERIMENTAL
Intervention: Passive role preference
Number of subjects: 3883

Group type: EXPERIMENTAL
Intervention: Active role preference
Number of subjects: 3883
Study: 17632215

Group type: EXPERIMENTAL
Intervention: Olanzapine (5-20 mg/d)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Chlorpromazine (200-800 mg/d)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 123

Group type: COMPARATOR
Intervention: Chlorpromazine
Number of subjects: 123
Study: 15642062

Group type: EXPERIMENTAL
Intervention: Stabilized 0.454% stannous fluoride/sodium hexametaphosphate dentifrice
Number of subjects: 143

Group type: COMPARATOR
Intervention: Negative control dentifrice
Number of subjects: 143
Study: 12392239

Group type: EXPERIMENTAL
Intervention: Deep acupuncture treatment
Number of subjects: 58

Group type: COMPARATOR
Intervention: Superficial (placebo) acupuncture treatment
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Both groups (deep and superficial acupuncture)
Number of subjects: 58
Study: 9893072

Group type: EXPERIMENTAL
Intervention: Fracture group
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study: 7482020

Group type: EXPERIMENTAL
Intervention: Harrington rods
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: AO internal fixator
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Posterior segmental fixator
Number of subjects: 67
Study: 2268811

Group type: EXPERIMENTAL
Intervention: Four doses of cefazolin
Number of subjects: 312

Group type: EXPERIMENTAL
Intervention: One dose of cefazolin and three doses of placebo
Number of subjects: 312

Group type: COMPARATOR
Intervention: Placebo (four doses)
Number of subjects: 312
Study: 7000475

Group type: EXPERIMENTAL
Intervention: Cimetidine (1.6 g/day)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study: 31689865

Group type: EXPERIMENTAL
Intervention: Contact needle therapy (CNT) added to usual care
Number of subjects: 120

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 120
Study: 27650135

Group type: EXPERIMENTAL
Intervention: Hydroxyethyl starch 600/0.75
Number of subjects: 8

Group type: COMPARATOR
Intervention: Hydroxyethyl starch 130/0.4
Number of subjects: 8
Study: 26503139

Group type: EXPERIMENTAL
Intervention: Girls First (combination of Girls First Resilience Curriculum and Girls First Health Curriculum)
Number of subjects: 3560

Group type: EXPERIMENTAL
Intervention: Girls First Resilience Curriculum (RC) alone
Number of subjects: 3560

Group type: EXPERIMENTAL
Intervention: Girls First Health Curriculum (HC) alone
Number of subjects: 3560

Group type: COMPARATOR
Intervention: School-as-usual control group (SC)
Number of subjects: 3560
Study: 23484181

Group type: EXPERIMENTAL
Intervention: EMD + BG + GTR
Number of subjects: 30

Group type: COMPARATOR
Intervention: BG + GTR
Number of subjects: 30

Group type: COMPARATOR
Intervention: OFD
Number of subjects: 30
Study: 21888038

Group type: EXPERIMENTAL
Intervention: Clostridium butyricum supplementation (1 x 10(9) CFU/kg diet)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: Clostridium butyricum supplementation
Number of subjects: 168
Study: 19657122

Group type: EXPERIMENTAL
Intervention: Vertebroplasty
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control (simulated procedure without cement)
Number of subjects: 131
Study: 17553058

Group type: EXPERIMENTAL
Intervention: Silicone membrane applied for 23 hours per day for 3 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Silicone membrane applied for 8 hours per day
Number of subjects: 0
Study: 15555501

Group type: EXPERIMENTAL
Intervention: Affiliation Arousal (Bridges of Madison County)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Power Arousal (The Godfather II)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (Documentary about the Amazon)
Number of subjects: 60
Study: 11133627

Group type: EXPERIMENTAL
Intervention: Clonidine (n = 20): interscalene block with 40 mL of 0.5% bupivacaine with epinephrine and 150 microg (=1 mL) of clonidine, completed by 1 mL of 0.9% saline IM.
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Control (n = 20): interscalene block with 40 mL of 0.5% bupivacaine with epinephrine and 1 mL of 0.9% saline, completed by 150 microg (=1 mL) of clonidine IM.
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (n = 20): interscalene block with 40 mL of 0.5% bupivacaine with epinephrine (1/200000) and 1 mL of 0.9% saline, completed by 1 mL of 0.9% saline IM in the controlateral shoulder.
Number of subjects: 60
Study: 10036515

Group type: EXPERIMENTAL
Intervention: Nurse-led shared care scheme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 8279405

Group type: EXPERIMENTAL
Intervention: Oat-based cereal
Number of subjects: 64

Group type: COMPARATOR
Intervention: Cereal containing no oats
Number of subjects: 64
Study: 2525470

Group type: EXPERIMENTAL
Intervention: Fenretinide (HPR) 300 mg daily for 6 months
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Fenretinide (HPR) 200 mg daily for 6 months, then 200 mg for another 6 months
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 31714321

Group type: EXPERIMENTAL
Intervention: Passionflower extract
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 29627750

Group type: EXPERIMENTAL
Intervention: Interactive cognitive motor training (24 sessions of 30-min training per week for 8 weeks)
Number of subjects: 62
Study: 28441971

Group type: EXPERIMENTAL
Intervention: Stratified care
Number of subjects: 470

Group type: COMPARATOR
Intervention: Non-stratified care
Number of subjects: 470
Study: 26670370

Group type: EXPERIMENTAL
Intervention: Levothyroxine capsules with esomeprazole (80 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Levothyroxine tablets with esomeprazole (80 mg)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Levothyroxine capsules after esomeprazole administration
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Levothyroxine tablets after esomeprazole administration
Number of subjects: 32

Group type: COMPARATOR
Intervention: Levothyroxine capsules without esomeprazole
Number of subjects: 32

Group type: COMPARATOR
Intervention: Levothyroxine tablets without esomeprazole
Number of subjects: 32
Study: 24534318

Group type: EXPERIMENTAL
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Endotracheal Intubation (TT)
Number of subjects: 76
Study: 21820424

Group type: EXPERIMENTAL
Intervention: Propylthiouracil (PTU) treatment for 6 weeks and 12 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Propylthiouracil (PTU) treatment
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (10 subjects)
Number of subjects: 25
Study: 18500081

Group type: EXPERIMENTAL
Intervention: Cyclosporine 0.05% drops twice daily for 3 months
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (standard postoperative LASIK medication)
Number of subjects: 22
Study: 16990383

Group type: EXPERIMENTAL
Intervention: Intracoronary injection of autologous mononuclear bone marrow cells (BMC)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (no aspiration or sham injection)
Number of subjects: 100
Study: 15160543

Group type: EXPERIMENTAL
Intervention: 10 ml of 2% lignocaine hydrochloride gel at 4 degrees C
Number of subjects: 40

Group type: COMPARATOR
Intervention: 10 ml of 2% lignocaine hydrochloride gel at 22 degrees C
Number of subjects: 40
Study: 14635310

Group type: EXPERIMENTAL
Intervention: Static night traction
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Orthoses
Number of subjects: 5

Group type: COMPARATOR
Intervention: No intervention (A)
Number of subjects: 5
Study: 9080938

Group type: EXPERIMENTAL
Intervention: DTwP
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: DTaP-SB
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: DTaP-CB
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: DTaP recipients
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccines
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: CMI responses
Number of subjects: 142
Study: 8020031

Group type: EXPERIMENTAL
Intervention: Full anticoagulation
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Low-dose warfarin (INR = 1.5-2.7)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Aspirin, 325 mg/day
Number of subjects: 4

Group type: COMPARATOR
Intervention: Aspirin, 75 mg/day
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Indobufene, 100 mg bid
Number of subjects: 4

Group type: COMPARATOR
Intervention: Aspirin or indobufene or nothing
Number of subjects: 4
Study: 3963031

Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Diazepam
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Alcohol with drug treatment
Number of subjects: 24
Study: 31299766

Group type: EXPERIMENTAL
Intervention: Abobotulinum toxin‐A injection (Group 1, n=20)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dry needling (Group 2, n=20)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups (Group 1 and Group 2)
Number of subjects: 40
Study: 27583688

Group type: EXPERIMENTAL
Intervention: Vandetanib (100 mg daily) with platinum (cisplatin or carboplatin) and etoposide
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo with platinum (cisplatin or carboplatin) and etoposide
Number of subjects: 68
Study: 26374703

Group type: EXPERIMENTAL
Intervention: Minocycline (100 mg once daily, increased to 200 mg at two weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 40
Study: 23426344

Group type: EXPERIMENTAL
Intervention: HA membrane (n = 41)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Standard management (n = 13)
Number of subjects: 54
Study: 21509636

Group type: EXPERIMENTAL
Intervention: Flexi-Slip stylet
Number of subjects: 160

Group type: COMPARATOR
Intervention: Introducer
Number of subjects: 160
Study: 19785978

Group type: EXPERIMENTAL
Intervention: Adaptive intervention
Number of subjects: 30

Group type: COMPARATOR
Intervention: Drug court as usual
Number of subjects: 30
Study: 17195727

Group type: EXPERIMENTAL
Intervention: Utrecht Coping Power Program (UCPP)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Care as Usual (CU)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Both treatment groups (UCPP and CU)
Number of subjects: 61
Study: 12855087

Group type: EXPERIMENTAL
Intervention: Virtual reality distraction intervention during chemotherapy treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: No distraction intervention (control condition) during alternate chemotherapy treatment
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Virtual reality distraction intervention
Number of subjects: 16
Study: 11297002

Group type: EXPERIMENTAL
Intervention: Isometric contractions at 10% of MVC
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isometric contractions at 20% of MVC
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isometric contractions at 30% of MVC
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isometric contractions at 40% of MVC
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isometric contractions at 50% of MVC
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isometric contractions at 60% of MVC
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isometric contractions at 70% of MVC
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isometric contractions at 80% of MVC
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Isometric contractions at 90% of MVC
Number of subjects: 30
Study: 8637514

Group type: EXPERIMENTAL
Intervention: TNFR:Fc (0.15 mg/kg)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: TNFR:Fc (0.45 mg/kg)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: TNFR:Fc (1.5 mg/kg)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141
Study: 1888816

Group type: EXPERIMENTAL
Intervention: Renzapride (0.5, 1.0, or 2.0 mg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 6828933

Group type: EXPERIMENTAL
Intervention: Antacids
Number of subjects: 33
Study: 2862139

Group type: EXPERIMENTAL
Intervention: Molindone
Number of subjects: 11

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 11
Study: 29684391

Group type: EXPERIMENTAL
Intervention: Nitrofurantoin 100 mg twice daily for 7 days preoperatively
Number of subjects: 86

Group type: COMPARATOR
Intervention: No oral antibiotics
Number of subjects: 86
Study: 28004007

Group type: EXPERIMENTAL
Intervention: CGM pre-CSII
Number of subjects: 22
Study: 23987242

Group type: EXPERIMENTAL
Intervention: Controlled orthodontic intrusive forces applied for 24 hours
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (no intrusive forces)
Number of subjects: 8
Study: 22878586

Group type: EXPERIMENTAL
Intervention: Warm-up (15 minutes of practice on a laparoscopic bench model)
Number of subjects: 14

Group type: COMPARATOR
Intervention: No warm-up
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Warm-up
Number of subjects: 14
Study: 21105276

Group type: EXPERIMENTAL
Intervention: FTO rs9939609 variant homozygous risk allele A
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: Antipsychotic treatment
Number of subjects: 239

Group type: COMPARATOR
Intervention: Other single nucleotide polymorphisms
Number of subjects: 239
Study: 18437356

Group type: EXPERIMENTAL
Intervention: Pressure support reduction from 20.0 cm H(2)O to 13.0 cm H(2)O
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Shortening the insufflation time
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Applying positive end-expiratory pressure
Number of subjects: 12
Study: 16177201

Group type: EXPERIMENTAL
Intervention: High Glycemic Index (HGI) diet
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Low Glycemic Index (LGI) diet
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: High Fat (HF) diet
Number of subjects: 29
Study: 12568832

Group type: EXPERIMENTAL
Intervention: Oral E2, 1 mg
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Oral E2, 1 mg plus gestodene, 25 microg
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Transdermal 17beta‐E2, 50 microg
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 11007679

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) - anaritide, 0.2 microgram/kg/min, 24-hour infusion
Number of subjects: 222

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 222
Study: 8698449

Group type: EXPERIMENTAL
Intervention: Mibefradil 25 mg
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Mibefradil 50 mg
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Mibefradil 100 mg
Number of subjects: 202

Group type: EXPERIMENTAL
Intervention: Mibefradil 150 mg
Number of subjects: 202

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 202
Study: 12796951

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound (Group 2)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Abdominal ultrasound (Group 1)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Transvaginal ultrasound
Number of subjects: 38
Study: 6695841

Group type: EXPERIMENTAL
Intervention: Small meal (less than or equal to 25% of energy needs)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Medium and large meals (greater than or equal to 35% of daily energy needs)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: All meal sizes (15 to 75% of daily energy requirements)
Number of subjects: 8
Study: 30668589

Group type: EXPERIMENTAL
Intervention: FW-4EB (barbell deadlift with four elastic bands)
Number of subjects: 15

Group type: COMPARATOR
Intervention: FW-2EB (barbell deadlift with two elastic bands)
Number of subjects: 15

Group type: COMPARATOR
Intervention: FW (barbell deadlift with free weights)
Number of subjects: 15
Study: 30260480

Group type: EXPERIMENTAL
Intervention: Low-ferritin donors informed and not called for 6 months to book a donation
Number of subjects: 12595

Group type: EXPERIMENTAL
Intervention: Low-ferritin donors
Number of subjects: 12595

Group type: COMPARATOR
Intervention: Normal-ferritin donors
Number of subjects: 12595
Study: 27296899

Group type: EXPERIMENTAL
Intervention: Structured, supervised exercise program focused on strengthening, along with prescribed home exercises; half received arthroscopic partial meniscectomy.
Number of subjects: 325

Group type: COMPARATOR
Intervention: Control group (no arthroscopic partial meniscectomy).
Number of subjects: 325
Study: 25187485

Group type: EXPERIMENTAL
Intervention: CYP2C19*2 (a reduced activity allele)
Number of subjects: 42

Group type: COMPARATOR
Intervention: CYP2C19 genotype
Number of subjects: 42
Study: 22368133

Group type: EXPERIMENTAL
Intervention: Sonographically guided-office-based
Number of subjects: 57

Group type: COMPARATOR
Intervention: Classic open-day surgery
Number of subjects: 57

Group type: COMPARATOR
Intervention: Wide-awake-office-based
Number of subjects: 57
Study: 20650444

Group type: EXPERIMENTAL
Intervention: Renal artery stenting
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Best medical treatment plus renal artery stenting
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best medical treatment
Number of subjects: 0
Study: 18397817

Group type: EXPERIMENTAL
Intervention: Steviol glycoside stevioside: 250mg t.d.s.
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 3
Study: 15853100

Group type: EXPERIMENTAL
Intervention: Bur followed by acid etching
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Bur
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Air abrasion followed by acid etching
Number of subjects: 56

Group type: COMPARATOR
Intervention: Air abrasion
Number of subjects: 56
Study: 12426415

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 33

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 33
Study: 10584049

Group type: EXPERIMENTAL
Intervention: Green tea extract (50 mg caffeine and 90 mg epigallocatechin gallate)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Caffeine (50 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8915226

Group type: EXPERIMENTAL
Intervention: salmeterol/SO2
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo/SO2
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: salmeterol
Number of subjects: 10

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 10
Study: 1876958

Group type: EXPERIMENTAL
Intervention: Inflatable birth canal dilator
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (no dilator)
Number of subjects: 30
Study: 7088636

Group type: EXPERIMENTAL
Intervention: Cow's milk formula (Enfamil)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Soy formula (ProSobee)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Hydrolyzed casein formula (Nutramigen)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cow's milk-based formula
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cow's milk
Number of subjects: 60
Study: 31007506

Group type: EXPERIMENTAL
Intervention: VAC therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional dressing
Number of subjects: 60
Study: 29020356

Group type: EXPERIMENTAL
Intervention: LILRB5 Asp247 variant
Number of subjects: 0
Study: 25793707

Group type: EXPERIMENTAL
Intervention: 400 mg sodium valproate
Number of subjects: 72

Group type: COMPARATOR
Intervention: 16 mg dexamethasone
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 400 mg sodium valproate (patients with aura)
Number of subjects: 72

Group type: COMPARATOR
Intervention: 16 mg dexamethasone (patients with aura)
Number of subjects: 72
Study: 23715256

Group type: EXPERIMENTAL
Intervention: Passive Static Stretching (PSS, N=11)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Hold-relax (HR, N=9)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Active Isolated Stretching (AIS, N=9)
Number of subjects: 38
Study: 21341959

Group type: EXPERIMENTAL
Intervention: Parents' Matter! Program (PMP) intervention
Number of subjects: 339
Study: 19293315

Group type: EXPERIMENTAL
Intervention: Any X-ray examination of the mother during pregnancy
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: X-ray exposure during the first trimester
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: X-ray exposure during the third trimester
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: X-ray exposure during the second trimester
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Any X-rays of the abdomen, pelvis, chest, or back
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Other X-ray exposures (primarily dental X-rays)
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: First trimester exposure and embryonal rhabdomyosarcoma
Number of subjects: 638
Study: 17476567

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) infusion
Number of subjects: 16

Group type: COMPARATOR
Intervention: Vehicle infusion (control)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) infusion during hyperglycaemia
Number of subjects: 16
Study: 15221621

Group type: EXPERIMENTAL
Intervention: Splinting
Number of subjects: 120

Group type: COMPARATOR
Intervention: Proximal steroid injections (betamethasone)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Distal steroid injections (betamethasone)
Number of subjects: 120
Study: 12193270

Group type: EXPERIMENTAL
Intervention: Electro-chemically activated water (ECA) at pH 7.0
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Electro-chemically activated water (ECA) at pH 9.0
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Sodium hypochlorite (NaOCl) 3.5%
Number of subjects: 60

Group type: COMPARATOR
Intervention: Distilled water (control)
Number of subjects: 60
Study: 9330411

Group type: EXPERIMENTAL
Intervention: Preoperative chemoradiation plus surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery or radiation alone
Number of subjects: 0
Study: 8502438

Group type: EXPERIMENTAL
Intervention: Therapeutic touch
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo control intervention (mimicking therapeutic touch)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Narcotic analgesic (standard intervention)
Number of subjects: 108